The sale is small relative to market cap and appears to be part of a pre-arranged 10b5-1 plan, reducing the likelihood of a negative signal. Monitor for any acceleration of insider selling or changes in the 10b5-1 plan terms.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Oct 29 $31.48entry
- T+1 · 7d ago −3.53%α −3.05% · $30.37
- T+5 · due 13h ago Pending
- T+5 · todayOpen
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Atul Dandekar, an officer of Maze Therapeutics, filed a Form 144 notice of intent to sell 15,000 shares of common stock, with an estimated aggregate market value of $475,950. The sale is planned for October 29, 2026, and the shares are to be acquired through the exercise of stock options. The proposed sale represents a modest portion of the insider's holdings and the company's $1.8B market cap, and is part of a pre-arranged 10b5-1 trading plan.
Key Facts
- Insider Atul Dandekar (Officer) filed Form 144 to sell 15,000 shares.
- Estimated aggregate market value of the proposed sale is $475,950.
- Sale is planned for October 29, 2026.
- Shares will be acquired through exercise of stock options.
- The filing references a 10b5-1 trading plan with prior sales on 08/28/2026 (7,500 shares) and 09/29/2026 (7,500 shares).
- Maze Therapeutics has a market cap of $1.8B; the sale represents ~0.026% of market cap.
Financial Impact
Proposed sale of 15,000 shares valued at $475,950, which is approximately 0.026% of the company's $1.8B market cap.
Risk Factors
- Insider selling, even under a 10b5-1 plan, can signal reduced confidence if it accelerates or increases in size.
- The filing is an intent to sell; the actual sale may not occur.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010485 |
| Document: 0001950047-26-010485-index.html | 0001950047-26-010485 |
| Document: 0001950047-26-010485.txt | 0001950047-26-010485 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 4, 2026 1d ago | Insider Cluster | $33.00 | awaiting T+5 | awaiting T+5 | $32.53 (−1.42%) |
Nov 2, 2026 3d ago | 144 | $32.25 | awaiting T+5 | awaiting T+5 | $32.53 (+0.87%) |
Oct 29, 2026 7d ago | 144 | $31.48 | awaiting T+5 | awaiting T+5 | $32.53 (+3.34%) |
Oct 16, 2026 20d ago | 8-K | $29.70 $31.07 | ▲ +4.61% | ▲ +4.76% | $32.53 (+9.53%) |
Oct 2, 2026 5w ago | Insider Cluster | $26.43 $27.70 | ▼ −4.81% | ▼ −4.38% | $32.53 (−23.08%) |
Oct 1, 2026 5w ago | 144 | $26.43 $27.11 | ▲ +2.57% | ▲ +1.41% | $32.53 (+23.08%) |
Sep 8, 2026 8w ago | Insider Cluster | $24.58 $23.92 | ▲ +2.71% | ▲ +1.61% | $32.53 (−32.34%) |
Sep 4, 2026 8w ago | Insider Cluster | $26.37 $24.23 | ▼ −8.12% | ▼ −7.00% | $32.53 (+23.36%) |
Sep 4, 2026 8w ago | Insider Cluster | $26.37 $24.23 | ▼ −8.12% | ▼ −7.00% | $32.53 (+23.36%) |
Sep 3, 2026 9w ago | Insider Cluster | $26.21 $24.67 | ▼ −5.88% | ▼ −4.67% | $32.53 (+24.11%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers